Your search for

30 results were returned

  1. Twobirds news
    05 April 2019
    Bird & Bird advises Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in Vakzine Projekt Management GmbH
    www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-serum-institute-of-india-pvt-ltd-on-the

    International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...

  2. Twobirds news
    01 June 2020
    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB
    www.twobirds.com/en/news/press-releases/2020/czech-republic/bird-and-bird-law-firm-advised-indian-vaccine-manufacturer-serum-institute-of-india-pvt-ltd

    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...

  3. Twobirds news
    22 July 2020
    Bird & Bird advises InGeneron on divestment of Eticur GmbH
    www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-advises-ingeneron-on-divestment-of-eticur-gmbh

    Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.

  4. Twobirds news
    24 May 2019
    Bird & Bird advises FUJIFILM on the 100% acquisition of medwork
    www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-fujifilm-on-the-100-acquisition-of-medwork

    International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy

  5. Legal news
    24 January 2020
    Access to documents contained in a MA application file
    www.twobirds.com/en/news/articles/2020/france/acces-aux-documents-contenus-dans-le-dossier-d-une-demande-amm

    European Medicines Agency (EMA) had communicated to third parties (with some omissions), information contained in toxicological test reports and clinical trial reports obtained in a MA application file on the grounds ...

  6. Twobirds news
    24 April 2020
    Bird & Bird team shortlisted in multiple categories for the 8th annual LMG Life Sciences Awards 2020 Europe
    www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-team-shortlisted-in-multiple-categories-for-the-8th-annual-lmg-life-sciences-awards

    Our international Life Sciences & Healthcare Group is extremely proud to have been recognised among individuals and companies behind the most innovative and challenging Life Sciences work of the past year, as well as ...

  7. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  8. Twobirds news
    28 February 2020
    Bird & Bird advises Mitsubishi Chemical Corporation on the acquisition of c-m-p
    www.twobirds.com/en/news/press-releases/2020/germany/bird-beraet-mitsubishi-chemical-corporation

    International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...